Replies to post #11852 on Genta, Inc (fka GNTAQ)

[prsch3259]

They will most likely fund ongoing developments through many options. Some you have already mentioned. Also see below:

Lastly, we have announced our intention to seek a buyer for Ganite®, our sole marketed product. Our financial constraints have prevented us from investing in adequate commercial support for Ganite®, and the intellectual property that provided us with an exclusive position in the United States has now expired.


We maintain an active Business Development program. We are seeking development and commercialization partners for our existing products and are seeking to acquire additional drugs that will enhance the value of our pipeline to our stockholders.